BPC157+TB500

This research blend combines BPC-157, a synthetic pentadecapeptide studied for its VEGFR2-mediated angiogenic and tissue-repair signaling, with TB500, a synthetic analog of the actin-binding protein Thymosin Beta-4 investigated for its roles in cellular migration, extracellular matrix remodeling, and vascular sprouting. The two compounds operate through complementary but mechanistically distinct pathways — BPC-157 acting on growth factor receptor signaling and nitric oxide cascades, while TB500’s active heptapeptide domain modulates actin polymerization and endothelial cell motility. Combined formulations are used in preclinical research contexts examining coordinated tissue regeneration and angiogenic response. Supplied as co-lyophilized powder, ≥99% purity. Store at -20°C. Research use only. Not for human consumption.